Dana W. Spigelman

Dana Spigelman represents private equity funds and their portfolio companies, as well as emerging companies, in mergers, acquisitions, equity investments, fund formation, capital raising, buyout transactions, dispositions, and other strategic transactions and general corporate matters. He works with a wide range of clients, but has particular experience in the technology, healthcare, life sciences, and consumer products industries.

Representative Engagements

  • Summit Partners in a growth funding round in CoderPad.
  • Representation of Perceptive Xontogeny Ventures in early-stage investments in drug development companies, such as AsclepiX Therapeutics and CereVasc.
  • New Heritage Capital in its platform investment in DeWinter Group.
  • New Heritage Capital in its investment in Welcome Dairy Holdings.

Education & Credentials

Boston University School of Law
JD, 2017, magna cum laude
Syracuse University
BA, 2012



Dana's Insights